Merck & Co., Inc. (NYSE:MRK)

thinkstockphotos-522646895

The 4 Stocks That Weighed on the DJIA Friday

April 29, 2016: Markets opened lower Friday with healthcare and tech stocks taking the brunt of the punishment. This morning's report on PCE inflation showed inflation lower in April than ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The short interest data have been released for the April 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription Drugs, Pills

The World’s 15 Top Selling Drugs

Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical companies generate an ...
Read Full Story »
Vault Door

Apple Has $181 Billion Offshore

Apple Inc. (NASDAQ: AAPL) continues to be the American company with most money "parked" offshore. The amount has hit $181 billion. The fact that the sum is so high raises ...
Read Full Story »
Stock market tickers

The 4 Stocks That Buoyed the DJIA on Thursday

April 14, 2016: Markets opened slightly higher Thursday following rather cool data on the consumer price index and fewer new claims for unemployment benefits than expected. Equities spent most of ...
Read Full Story »
Medicine pills

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the March 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Quotes

The 4 Stocks That Dominated the Dow on Wednesday

April 6, 2016: Markets opened higher on Wednesday following mixed trading in Asia. The dollar weakened and the release of the minutes from the FOMC's March meeting gave equities an ...
Read Full Story »
gavel and cash money

How Ionis Pharma Beat a Biotech Giant

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) led biotech stocks early on Wednesday following a key patent dispute win in the U.S. court system. The company announced that a jury in the U.S. ...
Read Full Story »
Medicine pills

Jefferies Top Drug Stocks for the Rest of 2016

One key analyst firm is continuing to look at which companies in the health care space are going to return the most in 2016. For the most part, Jefferies maintained ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Takes a Small Step Back

The short interest data have been released for the February 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Short Sellers Increase Bets in Major Pharma

The short interest data have been released for the February 12 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Short Sellers Increase Bets in Major Pharma

The short interest data have been released for the January 29 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Apple, Freeport-McMoRan, Kinross Gold, Pfizer, Plains All American, Salesforce, Tesla, Yelp and More

Stocks were getting pounded on Tuesday. The selling pressure seems to not have an end in 2016, even after investors successfully bought every dip for over four years. It still ...
Read Full Story »
Prescription drugs

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them ...
Read Full Story »
Medicine pills

How Analysts View Pfizer and Merck After Earnings

Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) released their most recent earnings reports last week. As a result, analysts weighed in on both of these pharmaceutical ...
Read Full Story »